SLC5A2 and type 2 diabetes mellitus: In type 2 diabetes mice models, the inhibition of SGLT2 also reduced glomerular macrophage infiltration and glomerular sclerosis [180] and attenuated the overexpression of NOX4, TGF-β, osteopontin, and MCP1 in the tubular cells induced by high glucose [181].